Use of Dihydroorotate Dehydrogenase Inhibitors for Treatment of Autoimmune Diseases and Cancer
Ahmed F. Abdel‐Magid
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVPatent HighlightNEXTUse of Dihydroorotate Dehydrogenase Inhibitors for Treatment of Autoimmune Diseases and CancerAhmed F. Abdel-Magid*Ahmed F. Abdel-MagidTherachem Research Medilab, LLC, 100 Jade Park, Chelsea, Alabama 35043, United States*Email: [email protected]More by Ahmed F. Abdel-Magidhttp://orcid.org/0000-0001-7438-1414Cite this: ACS Med. Chem. Lett. 2020, 11, 11, 2072–2074Publication Date (Web):September 4, 2020Publication History Received23 August 2020Published online4 September 2020Published inissue 12 November 2020https://pubs.acs.org/doi/10.1021/acsmedchemlett.0c00466https://doi.org/10.1021/acsmedchemlett.0c00466editorialACS PublicationsCopyright © 2020 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views3569Altmetric-Citations5LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (971 KB) Get e-AlertscloseSUBJECTS:Cancer,Inhibitors,Monomers,Peptides and proteins,Pyrimidine Get e-Alerts